Guruprasad Ranganatha Rao Kaginele, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 631 1st St Se, Faribault, MN 55021 Phone: 507-334-6451 Fax: 507-333-5511 |
Dr. Allan W Dale, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 State Ave, Faribault, MN 55021 Phone: 507-334-6451 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-PCS, an RNAi therapeutic targeting proprotein convertase subtilisin/kexin type 9, or PCSK9, for the treatment of severe hypercholesterolemia.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and active pharmaceutical ingredients today provided further updates on the business development of its flagship product: Gingko Mihuan Oral Liquid with the SFDA approval number: H20013079.
In the first study of its kind, LSU Health New Orleans researchers report that women's pre-pregnancy overweight or obesity produces changes in breast milk, which can affect infant growth.
› Verified 1 days ago